发明公开
EP0715855A3 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
失效
用于治疗呕吐的NK-1受体拮抗剂和5HT3受体拮抗剂
- 专利标题： NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
- 专利标题（中）： 用于治疗呕吐的NK-1受体拮抗剂和5HT3受体拮抗剂
-
申请号： EP95308273.2申请日： 1995-11-20
-
公开(公告)号： EP0715855A3公开(公告)日： 1999-01-20
- 发明人: Gonsalves, Susan F.
- 申请人： PFIZER INC.
- 申请人地址： 235 East 42nd Street New York, N.Y. 10017 US
- 专利权人： PFIZER INC.
- 当前专利权人： PFIZER INC.
- 当前专利权人地址： 235 East 42nd Street New York, N.Y. 10017 US
- 代理机构： Hayles, James Richard
- 优先权： US353049 19941209
- 主分类号： A61K45/06
- IPC分类号： A61K45/06
摘要：
The present invention relates to a method of treating or preventing emesis in a mammal, including a human, by administering to the mammal a 5HT 3 receptor antagonist and an NK-1 receptor antagonist ( e.g. , a substance P receptor antagonist). It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a 5HT 3 receptor antagonist and an NK-1 receptor antagonist.
公开/授权文献
信息查询
